Live feed
Filing
SC 13G/A
SC 13G/A0000902219-19-000254·Syndax Pharmaceuticals Inc
Schedule 13G ownership disclosure
Syndax Pharmaceuticals Inc
Security class unavailable · CUSIP: 87164F105
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,241,782
- Percent of class
- 13.0500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-19-000254
- Form type
- SC 13G/A
- Filer
- Syndax Pharmaceuticals Inc
- CIK
- CIK 1395937
- Filed
- Feb 12, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership